Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 12
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140912/ATZZG22C22226JZ2222L2ZZI8EE4Z22R5R62
Filed on: September 12, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
- TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare
- Festi hf.: Presentation of Q1 2024 results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
